Short stature
Conditions
Interventions
Experimental group :The experimental group received growth hormone therapy
Control group:The control group did not receive intervention
Sponsors
China People's Liberation Army Central Theater General Hospital
Eligibility
Sex/Gender
All
Age
3 Years to 9 Years
Inclusion criteria
Inclusion criteria: Meets the diagnostic criteria for idiopathic short stature in children (1. Height below 2 standard deviations (-2SD) of the average height of children of the same age, gender, and race; 2. Normal birth length and weight, with no history of rescue suffocation; 3. When the GH peak value of the growth hormone complex stimulation test is greater than 10ng/ml, GHD is excluded; 4. Normal or slightly delayed growth rate and bone age; 5. Exclude children with various diseases known to cause dwarfism, aged between 3-9 years old.
Exclusion criteria
Exclusion criteria: Infants who are younger than gestational age, have other serious endocrine disorders, cardiovascular diseases, genetic diseases, chromosomal diseases, or other diseases that affect growth and development.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting detection of FGF21;Klotho ; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood sugar;insulinum;Triglyceride (TG);Free fatty acid (FFA);Lipoprotein a (Lp-a); | — |
Countries
China
Contacts
Public ContactMinShu Zou
China People's Liberation Army Central Theater General Hospital
Outcome results
None listed